Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors
Clinical trial NCT01415297 · COMPLETED
Trial details
- NCT number
- NCT01415297
- Sponsor
- Niiki Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2012-05-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.